• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD8α 和 CD8β 亚基的细胞外结构域足以实现 TCR 工程化 CD4(+) T 细胞的 HLA Ⅰ类限制的辅助功能。

Extracellular domains of CD8α and CD8ß subunits are sufficient for HLA class I restricted helper functions of TCR-engineered CD4(+) T cells.

机构信息

Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

PLoS One. 2013 May 30;8(5):e65212. doi: 10.1371/journal.pone.0065212. Print 2013.

DOI:10.1371/journal.pone.0065212
PMID:23738014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3667802/
Abstract

By gene transfer of HLA-class I restricted T-cell receptors (TCRs) (HLA-I-TCR) into CD8(+) as well as CD4(+) T-cells, both effector T-cells as well as helper T-cells can be generated. Since most HLA-I-TCRs function best in the presence of the CD8 co-receptor, the CD8αß molecule has to be co-transferred into the CD4(+) T-cells to engineer optimal helper T-cells. In this study, we set out to determine the minimal part of CD8αβ needed for optimal co-receptor function in HLA-I-TCR transduced CD4(+) T-cells. For this purpose, we transduced human peripheral blood derived CD4(+) T-cells with several HLA-class I restricted TCRs either with or without co-transfer of different CD8 subunits. We demonstrate that the co-transduced CD8αβ co-receptor in HLA-I-TCR transduced CD4(+) T-cells behaves as an adhesion molecule, since for optimal antigen-specific HLA class I restricted CD4(+) T-cell reactivity the extracellular domains of the CD8α and ß subunits are sufficient.

摘要

通过将 HLA 类 I 限制性 T 细胞受体 (TCR)(HLA-I-TCR)基因转移到 CD8(+)和 CD4(+) T 细胞中,可以产生效应 T 细胞和辅助 T 细胞。由于大多数 HLA-I-TCR 在 CD8 共受体存在的情况下功能最佳,因此必须将 CD8αß 分子共转入 CD4(+) T 细胞中,以工程化最佳辅助 T 细胞。在这项研究中,我们着手确定用于 HLA-I-TCR 转导的 CD4(+) T 细胞中最佳共受体功能所需的 CD8αβ 的最小部分。为此,我们用几种 HLA 类 I 限制性 TCR 转导了人外周血来源的 CD4(+) T 细胞,要么共转导不同的 CD8 亚基,要么不共转导。我们证明,在 HLA-I-TCR 转导的 CD4(+) T 细胞中,共转导的 CD8αβ 共受体作为一种粘附分子发挥作用,因为对于最佳的抗原特异性 HLA 类 I 限制性 CD4(+) T 细胞反应,CD8α 和 ß 亚基的细胞外结构域就足够了。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8f2/3667802/babe9947478d/pone.0065212.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8f2/3667802/b0034e38726a/pone.0065212.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8f2/3667802/27334d7da7eb/pone.0065212.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8f2/3667802/babe9947478d/pone.0065212.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8f2/3667802/b0034e38726a/pone.0065212.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8f2/3667802/27334d7da7eb/pone.0065212.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8f2/3667802/babe9947478d/pone.0065212.g003.jpg

相似文献

1
Extracellular domains of CD8α and CD8ß subunits are sufficient for HLA class I restricted helper functions of TCR-engineered CD4(+) T cells.CD8α 和 CD8β 亚基的细胞外结构域足以实现 TCR 工程化 CD4(+) T 细胞的 HLA Ⅰ类限制的辅助功能。
PLoS One. 2013 May 30;8(5):e65212. doi: 10.1371/journal.pone.0065212. Print 2013.
2
HLA class II restricted T-cell receptor gene transfer generates CD4+ T cells with helper activity as well as cytotoxic capacity.HLA II类分子限制性T细胞受体基因转移可产生具有辅助活性以及细胞毒性能力的CD4+ T细胞。
Gene Ther. 2005 Dec;12(23):1686-95. doi: 10.1038/sj.gt.3302586.
3
Establishment of a novel NFAT-GFP reporter platform useful for the functional avidity maturation of HLA class II-restricted TCRs.建立一个新的 NFAT-GFP 报告平台,可用于 HLA Ⅱ类限制性 TCR 的功能亲和力成熟。
Cancer Immunol Immunother. 2023 Jul;72(7):2347-2356. doi: 10.1007/s00262-023-03420-8. Epub 2023 Mar 20.
4
Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.通过TCRαβ基因转移将人CD4 + T淋巴细胞重定向至MHC I类限制性黑色素瘤抗原MAGE-A1需要CD8α。
Gene Ther. 2005 Jan;12(2):140-6. doi: 10.1038/sj.gt.3302388.
5
A rare population of tumor antigen-specific CD4CD8 double-positive αβ T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells.一种罕见的肿瘤抗原特异性 CD4CD8 双阳性 αβ T 淋巴细胞群体,为工程化治疗性 T 细胞提供了独特的 CD8 非依赖性 TCR 基因。
J Immunother Cancer. 2019 Jan 9;7(1):7. doi: 10.1186/s40425-018-0467-y.
6
Enhancing Efficacy of TCR-engineered CD4 + T Cells Via Coexpression of CD8α.通过共表达 CD8α 增强 TCR 工程化 CD4 + T 细胞的功效。
J Immunother. 2023 May 1;46(4):132-144. doi: 10.1097/CJI.0000000000000456. Epub 2023 Feb 27.
7
In-vitro blockade of the CD4 receptor co-signal in antigen-specific T-cell stimulation cultures induces the outgrowth of potent CD4 independent T-cell effectors.在抗原特异性T细胞刺激培养物中对CD4受体共信号进行体外阻断可诱导强大的CD4非依赖性T细胞效应物的生长。
J Immunol Methods. 2018 Mar;454:80-85. doi: 10.1016/j.jim.2017.11.006. Epub 2017 Nov 14.
8
Avidity of human T cell receptor engineered CD4(+) T cells drives T-helper differentiation fate.人源化T细胞受体工程化CD4(+) T细胞的亲和力驱动辅助性T细胞分化命运。
Cell Immunol. 2016 Jan;299:30-41. doi: 10.1016/j.cellimm.2015.10.003. Epub 2015 Oct 23.
9
Development of genetically engineered CD4+ and CD8+ T cells expressing TCRs specific for a M. tuberculosis 38-kDa antigen.表达针对结核分枝杆菌 38 kDa 抗原的 TCR 的基因工程 CD4+和 CD8+ T 细胞的开发。
J Mol Med (Berl). 2011 Sep;89(9):903-13. doi: 10.1007/s00109-011-0760-4. Epub 2011 May 10.
10
MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro.MHC-I 限制性黑色素瘤抗原特异性 TCR 工程化的人 CD4+ T 细胞在体外表现出多功能效应器和辅助器反应。
Clin Immunol. 2010 Sep;136(3):338-47. doi: 10.1016/j.clim.2010.04.013. Epub 2010 May 23.

引用本文的文献

1
CD70 recruitment to the immunological synapse is dependent on CD20 in B cells.CD70募集至免疫突触取决于B细胞中的CD20。
Proc Natl Acad Sci U S A. 2025 Apr 22;122(16):e2414002122. doi: 10.1073/pnas.2414002122. Epub 2025 Apr 15.
2
Current developments in T-cell receptor therapy for acute myeloid leukemia.急性髓系白血病T细胞受体疗法的当前进展
Blood Adv. 2025 Jun 24;9(12):3069-3089. doi: 10.1182/bloodadvances.2024014105.
3
Vaccines for immunoprevention of DNA mismatch repair deficient cancers.用于预防 DNA 错配修复缺陷型癌症的疫苗。

本文引用的文献

1
PRAME-specific Allo-HLA-restricted T cells with potent antitumor reactivity useful for therapeutic T-cell receptor gene transfer.具有强大抗肿瘤反应性的 PRAME 特异性同种异体 HLA 限制 T 细胞,可用于治疗性 T 细胞受体基因转移。
Clin Cancer Res. 2011 Sep 1;17(17):5615-25. doi: 10.1158/1078-0432.CCR-11-1066. Epub 2011 Jul 19.
2
Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation.异基因干细胞移植后同时分离针对多种病毒的 CD8(+)和 CD4(+) T 细胞,以实现广泛的抗病毒免疫重建。
J Immunother. 2011 Apr;34(3):307-19. doi: 10.1097/CJI.0b013e318213cb90.
3
J Immunother Cancer. 2022 Jun;10(6). doi: 10.1136/jitc-2021-004416.
4
CRASH-IT Switch Enables Reversible and Dose-Dependent Control of TCR and CAR T-cell Function.CRASH-IT 开关可实现 TCR 和 CAR T 细胞功能的可逆和剂量依赖性控制。
Cancer Immunol Res. 2021 Sep;9(9):999-1007. doi: 10.1158/2326-6066.CIR-21-0095. Epub 2021 Jun 30.
5
A T-cell reporter platform for high-throughput and reliable investigation of TCR function and biology.一种用于T细胞受体(TCR)功能和生物学高通量且可靠研究的T细胞报告平台。
Clin Transl Immunology. 2020 Nov 23;9(11):e1216. doi: 10.1002/cti2.1216. eCollection 2020.
6
Transgenic CD8αβ co-receptor rescues endogenous TCR function in TCR-transgenic virus-specific T cells.转基因CD8αβ共受体可挽救T细胞受体转基因病毒特异性T细胞中的内源性TCR功能。
J Immunother Cancer. 2020 Nov;8(2). doi: 10.1136/jitc-2020-001487.
7
Single-cell transcriptomics identifies multiple pathways underlying antitumor function of TCR- and CD8αβ-engineered human CD4 T cells.单细胞转录组学鉴定 TCR 和 CD8αβ 工程化人 CD4 T 细胞抗肿瘤功能的多个途径。
Sci Adv. 2020 Jul 3;6(27):eaaz7809. doi: 10.1126/sciadv.aaz7809. eCollection 2020 Jul.
8
Engineering Strategies to Enhance TCR-Based Adoptive T Cell Therapy.工程策略增强 TCR 为基础的过继性 T 细胞治疗。
Cells. 2020 Jun 18;9(6):1485. doi: 10.3390/cells9061485.
9
Development of T-cell immunotherapy for hematopoietic stem cell transplantation recipients at risk of leukemia relapse.开发 T 细胞免疫疗法,用于有白血病复发风险的造血干细胞移植受者。
Blood. 2018 Jan 4;131(1):108-120. doi: 10.1182/blood-2017-07-791608. Epub 2017 Oct 19.
10
Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cells.关键生物学参数调节亲和力,作为T细胞受体基因修饰T细胞功能的决定因素。
Cancer Immunol Immunother. 2017 Nov;66(11):1411-1424. doi: 10.1007/s00262-017-2032-9. Epub 2017 Jun 20.
Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1.
采用针对 NY-ESO-1 的基因工程化淋巴细胞治疗转移性滑膜细胞肉瘤和黑色素瘤患者的肿瘤消退。
J Clin Oncol. 2011 Mar 1;29(7):917-24. doi: 10.1200/JCO.2010.32.2537. Epub 2011 Jan 31.
4
Optimization of the HA-1-specific T-cell receptor for gene therapy of hematologic malignancies.优化 HA-1 特异性 T 细胞受体用于血液系统恶性肿瘤的基因治疗。
Haematologica. 2011 Mar;96(3):477-81. doi: 10.3324/haematol.2010.025916. Epub 2010 Nov 25.
5
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.使用人类和小鼠T细胞受体的基因疗法介导癌症消退,并靶向表达同源抗原的正常组织。
Blood. 2009 Jul 16;114(3):535-46. doi: 10.1182/blood-2009-03-211714. Epub 2009 May 18.
6
Kinetic preservation of dual specificity of coprogrammed minor histocompatibility antigen-reactive virus-specific T cells.共同编程的次要组织相容性抗原反应性病毒特异性T细胞双重特异性的动力学保存
Cancer Res. 2009 Mar 1;69(5):2034-41. doi: 10.1158/0008-5472.CAN-08-2523. Epub 2009 Feb 17.
7
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens.转移性黑色素瘤患者的过继性细胞疗法:强化清髓性放化疗预处理方案的评估
J Clin Oncol. 2008 Nov 10;26(32):5233-9. doi: 10.1200/JCO.2008.16.5449. Epub 2008 Sep 22.
8
CD8alpha/alpha homodimers fail to function as co-receptor for a CD8-dependent TCR.CD8α/α同二聚体无法作为CD8依赖性TCR的共受体发挥作用。
Eur J Immunol. 2007 Jun;37(6):1634-41. doi: 10.1002/eji.200636900.
9
Facilitating matched pairing and expression of TCR chains introduced into human T cells.促进引入人T细胞中的TCR链的匹配配对和表达。
Blood. 2007 Mar 15;109(6):2331-8. doi: 10.1182/blood-2006-05-023069. Epub 2006 Nov 2.
10
Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex.双特异性T细胞中T细胞受体表达的效率由TCR-CD3复合物中TCR链的内在特性控制。
Blood. 2007 Jan 1;109(1):235-43. doi: 10.1182/blood-2006-03-013318. Epub 2006 Sep 12.